Literature DB >> 1093922

Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral.

B W Trotman, E J Petrella, R D Soloway, H M Sanchez, T A Morris, W T Miller.   

Abstract

A major criterion for the selection of patients with gallstones for treatment with chenodeoxycholic acid is the radiographic demonstration of lucent gallstones. In this study, we sought to evaluate the degree of selectivity of that criterion for distinguishing patients with cholesterol stones from those with pigment stones and to define the determinants of stone lucency or opaqueness. Of 92 lucent stones, 14% were pigment stones; and of 18 of opaque stones, 33% were cholesterol. Thus, the criterion of stone lucency allows inclusion of a significant number of subjects (14%) with lucent pigment stones, which may account for about one-half of the reported 33% incidence of treatment failures with chenodeoxycholic acid. Conversely, of patients with opaque stones, the one-third with cholesterol stones would be excluded from chenodeoxycholic acid treatment. Calcium is the major metal of both types of stones. However, opaque stones contain 6 times more calcium than lucent stones, which accounts for the difference in radiographic appearance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1093922

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

1.  Gallstones.

Authors:  T A Bouchier
Journal:  Proc R Soc Med       Date:  1977-09

2.  The effect of phenobarbital on biliary lipid metabolism and hepatic microsomal drug metabolism in patients with cholesterol cholelithiasis.

Authors:  G W Hepner
Journal:  Am J Dig Dis       Date:  1976-05

3.  Chemical composition of gallstones resistant to dissolution therapy with chenodeoxycholic acid.

Authors:  M J Whiting; V Jarvinen; J M Watts
Journal:  Gut       Date:  1980-12       Impact factor: 23.059

4.  Management of stones in the biliary tree.

Authors:  R H Dowling
Journal:  Gut       Date:  1983-07       Impact factor: 23.059

Review 5.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

6.  Study of the sensitivity and specificity of computerized tomography in the detection of calcified gallstones which appears radiolucent by conventional roentgenography.

Authors:  R P Sarva; S Farivar; H Fromm; W Poller
Journal:  Gastrointest Radiol       Date:  1981

7.  Duodenal bile examination in identifying potential non-responders to bile salt treatment and its comparison with gall bladder bile examination.

Authors:  D K Agarwal; G Choudhuri; V A Saraswat; T S Negi; V K Kapoor; R Saxena
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.

Authors:  J H Iser; P N Maton; G M Murphy; R H Dowling
Journal:  Br Med J       Date:  1978-06-10

9.  Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy.

Authors:  M L Petroni; R P Jazrawi; A Grundy; A Lanzini; M G Pigozzi; A Biasio; K W Heaton; J Virjee; T C Northfield
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 10.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.